A report out of the oval office today has indicated Hydroxychloroquine has limited or no effectiveness in combating COVID-19 in a one-president study.
Hard Money will continue to report on this story as it unfolds and its impact on the markets. But at press time, Hydroxychloroquine futures had plummeted.
This form needs Javascript to display, which your browser doesn't support. Sign up here instead